Fibrocalculous pancreatic diabetes (FCPD).

Acta Diabetol

Dr. Mohan's Diabetes Specialities Centre, Madras Diabetes Research Foundation, WHO Collaborating Centre for Non-communicable Diseases Prevention and Control, IDF Centre of Education, 4, Conran Smith Road, Gopalapuram, Chennai, 600 086, India.

Published: February 2015

Fibrocalculous pancreatic diabetes (FCPD) is an uncommon form of diabetes that occurs as a result of chronic calcific pancreatitis, in the absence of alcohol abuse. The disease is restricted to tropical regions of the world, and southern India has the highest known prevalence of FCPD. The typical patient with FCPD is a lean adolescent or young adult of either sex, presenting with history of recurrent bouts of abdominal pain and steatorrhea. Demonstration of large, discrete pancreatic calculi by plain radiographs or ultrasonography of the abdomen is diagnostic. While the exact etiology of FCPD is unknown, genetic, nutritional and inflammatory factors have been hypothesized to play a role. Diabetes in FCPD is often brittle and difficult to control; most patients require multiple doses of insulin for control of glycemia. However, in spite of high blood glucose levels, patients rarely develop ketosis. Malabsorption responds to pancreatic enzyme supplementation. Surgical removal of stones is indicated for symptomatic relief of intractable pain. While patients with FCPD develop microvascular complications as frequently as those with type 2 diabetes, macrovascular disease is uncommon. Development of pancreatic malignancy is the most dreaded complication and should be suspected in any patient who complains of weight loss, back pain or jaundice.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00592-014-0685-9DOI Listing

Publication Analysis

Top Keywords

diabetes fcpd
12
fibrocalculous pancreatic
8
pancreatic diabetes
8
fcpd
7
diabetes
5
fcpd fibrocalculous
4
pancreatic
4
fcpd uncommon
4
uncommon form
4
form diabetes
4

Similar Publications

Article Synopsis
  • The study examined genetic mutations in SPINK1, PRSS1, PRSS2, CTRC, and CFTR among patients with Fibrocalcific pancreatic diabetes (FCPD), Type 2 Diabetes (T2DM), and healthy controls, focusing on the SPINK1 N34S mutation.
  • Whole blood samples were used for PCR and Sanger sequencing to identify these mutations, revealing the N34S variant's presence in 5.88% of FCPD patients, with no significant differences compared to T2DM and controls.
  • The in-silico analysis showed conflicting evidence regarding the N34S variant's role in disease, and while other mutations in SPINK1 and PRSS1 were identified in FCP
View Article and Find Full Text PDF

An Unusual Presentation of Extrapulmonary Tuberculosis in a Fibrocalculous Pancreatic Diabetes Patient.

J Assoc Physicians India

August 2024

Assistant Professor, Department of Medicine, Midnapore Medical College and Hospital, Medinipur, West Bengal, India, Corresponding Author.

Fibrocalculous pancreatic diabetes (FCPD) mellitus is a distinct type of diabetes that arises from chronic calcification of the pancreas in young, nonalcoholic individuals, predominantly in tropical regions. The characteristic triad of FCPD includes diabetes, abdominal pain, and steatorrhea. Additional notable features of the disease are its early age of onset, the presence of large intraductal stones, rapid disease progression, and a heightened risk of developing pancreatic cancer.

View Article and Find Full Text PDF

Aims: To study glycemic patterns and variability in patients with pancreatic diabetes or type 3c Diabetes mellitus (DM) due to chronic pancreatitis and its subtypes and assess the role of pancreatic enzyme replacement therapy (ERT) in modulating glycemic variability.

Methods: Patients having type 3c DM due to chronic pancreatitis, and on insulin underwent Flash continuous-glucose-monitoring (CGM) for 14 days. Parameters were compared between patients with fibrocalculous pancreatic diabetes (FCPD) and non-FCPD-chronic calcific pancreatitis (non-FCPD) and between the recipients and non-recipients of pancreatic enzyme-replacement-therapy (ERT).

View Article and Find Full Text PDF

Purpose: The present investigation deals with the impact of protein energy malnourished condition on the pharmacokinetic profile of glibenclamide. Protein energy malnourished condition leads to malnutrition related diabetes mellitus (MRDM), Fibrocalculus pancreatic diabetes mellitus (FCPD) or Lean body mass diabetes mellitus (LBMDM).

Method: In the present study, malnutrition was developed in female wistar rats using a modified protein deficient diet (0.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!